Mallinckrodt Pharmaceuticals is an industry leader in providing biopharmaceutical products. The company’s two business segments include Specialty Brands and Specialty Generics. Areas of focus include autoimmune and rare diseases; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. To learn more visit www.mallinckrodt.com.
To learn more or update your cookie preferences, see our disclaimer page.